Program
Saturday, September 14, 2024
-
-
-
Track: Plenary - Opening Symposium
Level: ANA2024
Speakers:
- A Successful RNA-Targeted Therapy for ALS
- C9orf72 ALS/FTD: Challenges and New Opportunities in Translational Research
- Human Genetic Therapies for ALS: Current Status and Future Prospects
- TDP43: A Focal Point for RNA Therapeutics in ALS/FTD
-
-
Level: ANA2024